Healthcare Foresights sees botulinum toxin in urology market reaching $1.98 billion by 2035

The market research firm said the sector was valued at about $1.1 billion in 2025 and projects a 6.08% CAGR from 2026 to 2035, with North America leading and Asia Pacific growing fastest.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.